Canadian Online Pharmacy

CDRH Transparency Update

You are subscribed to CDRH Transparency for U.S. Food & Drug Administration (FDA).

The following PMAs were added to Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes  

*P910077/S119

*P110042/S002

*P030005/S088

*P890003/S254

*P980016/S366

*P980035/S280

*P990001/S105

*P010015/S166

*P010031/S319

*P000009/S051

*P050023/S058

*P070008/S036

CDRH Transparency home page

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery